AUTHOR SUMMARY
Prions are unconventional agents that infect animals and humans and cause a family of degenerative brain diseases known as transmissible spongiform encephalopathy or prion diseases. It is difficult to inactivate prions so that they cannot infect hosts, and the biochemical nature of prions has not been precisely determined. In previous experiments using a protein misfolding cyclic amplification (PMCA) method, where misfolding of normal prion protein was initiated in cell-free test tube reactions by addition of a small amount of misfolded disease-associated proteaseresistant prion protein (PrPres), both infectivity and PrPres were generated. Because live cells were not present in these reactions, this result supported the hypothesis that prions are nonviral infectious agents. However, these experiments failed to quantitatively measure concentrations of infectivity to rule out contamination as a source for the results. In the present study, using methods for accurate quantitative measurement of both infectivity and PrPres, we detected newly generated prion infectivity and PrPres in PMCA products of three replicated experiments. These results provided strong support for the hypothesis that the agent of prion infectivity is not a virus. However, in making the comparisons to in vivo products, we found that the ratio of the infectivity concentration to the amount of PrPres was much lower in PMCA samples vs. brain-derived samples, implying that a substantial portion of PrPres generated in PMCA might be noninfectious.
The biochemical nature of the prion or transmissible spongiform encephalopathy infectious agent is the subject of intense interest. Previous studies have indicated that its size is similar to a small virus, but have also demonstrated that it is resistant to harsh chemicals or irradiation, which would usually harm and inactivate the genetic material of a virus. A "protein-only" agent was hypothesized by Griffith (1), and supporting evidence was presented by Prusiner et al. (2, 3) , who proposed that a version of the disease-associated host prion protein (PrPres or PrP Sc ) was the infectious agent. The authors further characterized this agent as a protein that was resistant to protease enzymes, which degrade most proteins, suggesting that the protein might be folded differently from the original version. In the present studies, we attempted to determine whether significant prion infectivity could be amplified in experiments where viruses could not grow, i.e., cell-free PMCA reactions (4, 5) . By quantifying PrPres concentration and infectivity, this study was also aimed at ruling out contamination as a source for the infectivity found in previous experiments.
In
Misfolding of the prion protein was initiated by addition of PrPres derived from prion disease-infected hamster brain. Reactions that used normal brain substrate showed generation of infectivity that persisted over four to eight serially passaged reactions at much higher levels than in negative control reactions. The infectivity detected in these experiments was substantial in amount and was not likely the result of any contamination. However, when the amount of infectivity was compared with the amount of PrPres, the ratio of infectivity per amount of PrPres was significantly lower in PMCA reaction products than in the original brain-derived materials (Fig. P1) . The lower specific infectivity in PMCA materials suggested that the PrPres generated in PMCA might not be as infectious as the PrPres generated from the brain. This lower specific infectivity might be due to the presence of some processes in the PMCA reaction that generate PrPres in another misfolded form that lacks infectivity. Alternatively, PrPres produced in the PMCA might lack an additional component needed for infectivity. These phenomena might, in turn, result from differences in the prion protein conversion conditions occurring in PMCA vs. those in living brain tissue.
The present results provide strong support for the hypothesis of a nonviral agent for transmissible spongiform encephalopathy/ Results represent data from one experiment using brains of tg7 mice genetically engineered to express prion protein encoded by hamster genes. Similar results were obtained in a second experiment using tg7 brain and in a third experiment using hamster brain. Infectivity concentration was quantified for the brain-derived input and the PMCA products obtained after specific numbers of rounds of PMCA by standard end-point dilution measurement methods using tg7 mice. In all experiments, new infectivity was generated during PMCA reactions; however, the ratio of infectivity to PrPres (specific infectivity) was much lower for PMCA-derived material than for brainderived material.
prion disease. Under PMCA conditions, where living cells are absent, virus assembly might be possible, but virus replication would not occur, because viruses depend on host cells to read and replicate their genetic material. Our experiments suggested that generation of PrPres itself might account for the new infectivity produced. Our findings indicate that the PrPres produced in vitro might be lower in infectivity relative to brainderived PrPres. To test the reasons for the lower infectivity found in PMCA-derived PrPres, structural studies would help to determine whether there are multiple PrPres structures generated in PMCA and in brain and which of these might account for the infectivity observed.
